SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-019242
Filing Date
2018-04-04
Accepted
2018-04-04 16:38:21
Documents
8
Period of Report
2018-04-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv490372_6k.htm 6-K 20062
2 EXHIBIT 4.1 tv490372_ex4-1.htm EX-4.1 89966
3 EXHIBIT 5.1 tv490372_ex5-1.htm EX-5.1 11031
4 EXHIBIT 5.2 tv490372_ex5-2.htm EX-5.2 11962
5 EXHIBIT 10.1 tv490372_ex10-1.htm EX-10.1 136644
6 GRAPHIC tv490372_ex5-1img1.jpg GRAPHIC 30603
7 GRAPHIC tv490372_ex5-1img2.jpg GRAPHIC 3444
8 GRAPHIC tv490372_ex5-2img1.jpg GRAPHIC 13720
  Complete submission text file 0001144204-18-019242.txt   336904
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 18737709
SIC: 2834 Pharmaceutical Preparations